Truist Financial Issues Pessimistic Forecast for American Healthcare REIT (NYSE:AHR) Stock Price

American Healthcare REIT (NYSE:AHR) had its price target reduced by analysts at Truist Financial from $53.00 to $52.00 in a research note issued to investors on Tuesday, MarketBeat reports. The brokerage presently has a “buy” rating on the stock. Truist Financial’s price objective would suggest a potential upside of 6.89% from the company’s previous close.

A number of other equities research analysts also recently weighed in on AHR. Zacks Research downgraded American Healthcare REIT from a “strong-buy” rating to a “hold” rating in a research note on Thursday, January 1st. JMP Securities upped their price objective on shares of American Healthcare REIT from $45.00 to $50.00 and gave the stock a “market outperform” rating in a report on Friday, October 17th. UBS Group raised their target price on American Healthcare REIT from $51.00 to $56.00 and gave the company a “buy” rating in a report on Monday, November 17th. Jefferies Financial Group reissued a “buy” rating on shares of American Healthcare REIT in a research note on Monday, December 15th. Finally, Citigroup increased their price target on American Healthcare REIT from $45.00 to $52.00 and gave the company a “neutral” rating in a report on Friday, November 21st. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, American Healthcare REIT has a consensus rating of “Moderate Buy” and a consensus target price of $51.55.

American Healthcare REIT Trading Up 2.6%

NYSE AHR opened at $48.65 on Tuesday. The company has a current ratio of 0.44, a quick ratio of 0.44 and a debt-to-equity ratio of 0.37. American Healthcare REIT has a 1-year low of $26.48 and a 1-year high of $51.01. The firm’s fifty day simple moving average is $48.36 and its 200-day simple moving average is $43.95. The company has a market capitalization of $8.61 billion, a PE ratio of 347.47, a price-to-earnings-growth ratio of 1.80 and a beta of 1.02.

Insider Activity

In other news, EVP Mark E. Foster sold 1,500 shares of the stock in a transaction that occurred on Tuesday, November 11th. The shares were sold at an average price of $49.35, for a total transaction of $74,025.00. Following the sale, the executive vice president directly owned 57,600 shares of the company’s stock, valued at $2,842,560. This represents a 2.54% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Jeffrey T. Hanson sold 35,570 shares of the business’s stock in a transaction dated Monday, December 22nd. The stock was sold at an average price of $48.38, for a total value of $1,720,876.60. Following the sale, the director directly owned 19,208 shares of the company’s stock, valued at $929,283.04. This represents a 64.93% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 76,288 shares of company stock worth $3,718,666. 0.92% of the stock is owned by corporate insiders.

Institutional Trading of American Healthcare REIT

Hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its holdings in shares of American Healthcare REIT by 2.7% during the 3rd quarter. Vanguard Group Inc. now owns 23,529,739 shares of the company’s stock valued at $988,484,000 after purchasing an additional 611,809 shares in the last quarter. State Street Corp raised its holdings in American Healthcare REIT by 6.5% during the 2nd quarter. State Street Corp now owns 6,902,944 shares of the company’s stock worth $255,289,000 after buying an additional 422,931 shares during the period. Invesco Ltd. lifted its stake in American Healthcare REIT by 15.9% in the second quarter. Invesco Ltd. now owns 5,820,530 shares of the company’s stock valued at $213,846,000 after buying an additional 798,075 shares in the last quarter. Alliancebernstein L.P. boosted its holdings in shares of American Healthcare REIT by 16.7% in the second quarter. Alliancebernstein L.P. now owns 5,318,866 shares of the company’s stock valued at $195,415,000 after buying an additional 759,501 shares during the period. Finally, Geode Capital Management LLC boosted its holdings in shares of American Healthcare REIT by 20.5% in the second quarter. Geode Capital Management LLC now owns 4,578,867 shares of the company’s stock valued at $174,882,000 after buying an additional 779,109 shares during the period. Institutional investors and hedge funds own 16.68% of the company’s stock.

About American Healthcare REIT

American Healthcare REIT, Inc (NYSE: AHR) was a publicly traded real estate investment trust focused on acquiring, owning and managing healthcare‐related properties across the United States. The company’s portfolio spanned senior housing communities, skilled nursing facilities, medical office buildings and outpatient care centers, all operated under long‐term net lease or triple‐net lease structures designed to provide stable, predictable rental income.

Employing a strategy of partnering with established healthcare operators, American Healthcare REIT targeted properties in both major metropolitan areas and high‐growth secondary markets to capitalize on demographic trends such as an aging population and increased demand for outpatient services.